Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. The firm is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The firm is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
The current price of SLGL is $83.8, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Sol Gel Technologies Ltd?
Sol Gel Technologies Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is Sol Gel Technologies Ltd market cap?
Sol Gel Technologies Ltd's current market cap is $233.8M
Is Sol Gel Technologies Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Sol Gel Technologies Ltd, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell